A detailed history of Waters Parkerson & Co., LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Waters Parkerson & Co., LLC holds 302,279 shares of MRK stock, worth $29.6 Million. This represents 1.74% of its overall portfolio holdings.

Number of Shares
302,279
Previous 306,732 1.45%
Holding current value
$29.6 Million
Previous $38 Million 9.6%
% of portfolio
1.74%
Previous 2.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$111.15 - $128.97 $494,950 - $574,303
-4,453 Reduced 1.45%
302,279 $34.3 Million
Q2 2024

Aug 12, 2024

SELL
$123.8 - $132.96 $191,023 - $205,157
-1,543 Reduced 0.5%
306,732 $38 Million
Q1 2024

May 14, 2024

SELL
$113.24 - $131.95 $1.46 Million - $1.7 Million
-12,883 Reduced 4.01%
308,275 $40.7 Million
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $993,985 - $1.08 Million
-9,922 Reduced 3.0%
321,158 $35 Million
Q3 2023

Nov 09, 2023

SELL
$102.95 - $114.33 $187,677 - $208,423
-1,823 Reduced 0.55%
331,080 $34.1 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $556,300 - $606,342
-5,122 Reduced 1.52%
332,903 $38.4 Million
Q1 2023

May 02, 2023

SELL
$102.94 - $114.86 $55,793 - $62,254
-542 Reduced 0.16%
338,025 $36 Million
Q4 2022

Feb 09, 2023

SELL
$87.44 - $112.11 $602,811 - $772,886
-6,894 Reduced 2.0%
338,567 $37.6 Million
Q3 2022

Nov 04, 2022

SELL
$84.53 - $94.96 $133,726 - $150,226
-1,582 Reduced 0.46%
345,461 $29.8 Million
Q2 2022

Aug 01, 2022

BUY
$83.49 - $94.64 $336,798 - $381,777
4,034 Added 1.18%
347,043 $31.6 Million
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $296,612 - $332,484
4,035 Added 1.19%
343,009 $28.1 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $772,456 - $967,600
-10,687 Reduced 3.06%
338,974 $26 Million
Q3 2021

Nov 04, 2021

BUY
$71.68 - $78.83 $357,898 - $393,598
4,993 Added 1.45%
349,661 $26.3 Million
Q2 2021

Aug 10, 2021

BUY
$70.31 - $77.77 $583,432 - $645,335
8,298 Added 2.47%
344,668 $26.8 Million
Q1 2021

May 12, 2021

BUY
$68.86 - $81.11 $1.11 Million - $1.3 Million
16,069 Added 5.02%
336,370 $25.9 Million
Q4 2020

Feb 10, 2021

BUY
$71.77 - $79.65 $308,036 - $341,857
4,292 Added 1.36%
320,301 $26.2 Million
Q3 2020

Nov 16, 2020

SELL
$73.18 - $82.95 $122,942 - $139,356
-1,680 Reduced 0.53%
316,009 $26.2 Million
Q2 2020

Aug 13, 2020

BUY
$70.42 - $80.13 $32,252 - $36,699
458 Added 0.14%
317,689 $24.6 Million
Q1 2020

May 11, 2020

BUY
$63.36 - $87.82 $691,067 - $957,852
10,907 Added 3.56%
317,231 $24.4 Million
Q4 2019

Feb 13, 2020

SELL
$77.58 - $87.54 $99,690 - $112,488
-1,285 Reduced 0.42%
306,324 $27.9 Million
Q3 2019

Nov 13, 2019

SELL
$76.08 - $82.93 $414,559 - $451,885
-5,449 Reduced 1.74%
307,609 $25.9 Million
Q2 2019

Aug 06, 2019

SELL
$69.84 - $81.59 $442,087 - $516,464
-6,330 Reduced 1.98%
313,058 $26.3 Million
Q1 2019

May 13, 2019

BUY
$69.58 - $79.36 $136,098 - $155,228
1,956 Added 0.62%
319,388 $26.6 Million
Q4 2018

Feb 12, 2019

SELL
$65.24 - $75.71 $108,950 - $126,435
-1,670 Reduced 0.52%
317,432 $24.3 Million
Q3 2018

Nov 13, 2018

BUY
$57.69 - $67.84 $54,401 - $63,973
943 Added 0.3%
319,102 $22.6 Million
Q2 2018

Aug 13, 2018

BUY
$50.83 - $59.72 $149,592 - $175,755
2,943 Added 0.93%
318,159 $19.3 Million
Q1 2018

May 09, 2018

BUY
$50.96 - $59.23 $871,212 - $1.01 Million
17,096 Added 5.73%
315,216 $17.2 Million
Q4 2017

Feb 09, 2018

BUY
$51.62 - $61.64 $1.07 Million - $1.27 Million
20,673 Added 7.45%
298,120 $16.8 Million
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $34,791 - $37,436
593 Added 0.21%
277,447 $17.8 Million
Q2 2017

Aug 11, 2017

BUY
N/A
276,854
276,854 $17.7 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Waters Parkerson & Co., LLC Portfolio

Follow Waters Parkerson & Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waters Parkerson & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waters Parkerson & Co., LLC with notifications on news.